Coya Therapeutics, Inc.
COYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835022
No open-market purchases or sales by Coya Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $45.5M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Coya Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +7 vs. Q3 2024
- Shares held
- 4.44M
- +1.13M (+34.1%) vs. Q3 2024
- Total value
- $25.5M
- +$4.08M (+19.1%) vs. Q3 2024
- New holders
- 8
- 12 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 54 | $45.5M |
| Q1 2026 | 57 | $32.0M |
| Q4 2025 | 58 | $46.0M |
| Q3 2025 | 36 | $27.1M |
| Q2 2025 | 33 | $25.8M |
| Q1 2025 | 26 | $30.2M |
| Q4 2024 | 26 | $25.5M |
| Q3 2024 | 19 | $21.4M |
| Q2 2024 | 19 | $19.8M |
| Q1 2024 | 19 | $33.1M |
| Q4 2023 | 21 | $20.6M |
| Q3 2023 | 15 | $5.45M |
| Q2 2023 | 14 | $5.50M |
| Q1 2023 | 7 | $4.37M |
| Q4 2022 | 4 | $5.16M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Coya Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 32 | $183 | 0.00% | +1+3.2% | Added |
| Bank of America Corp | 115 | $659 | 0.00% | +9+8.5% | Added |
| Steward Partners Investment Advisory, LLC | 500 | $2.87K | 0.00% | +500 | New |
| Jones Financial Companies LLLP | 600 | $3.44K | 0.00% | −5,450−90.1% | Reduced |
| SBI Securities Co., Ltd. | 761 | $4.36K | 0.00% | +761 | New |
| Morgan Stanley | 2,800 | $16.0K | 0.00% | +2,000+250.0% | Added |
| Advisor Group Holdings, Inc. | 3,342 | $19.1K | 0.00% | +1,468+78.3% | Added |
| Tower Research Capital LLC (TRC) | 5,252 | $30.1K | 0.00% | +4,777+1,005.7% | Added |
| XTX Topco Ltd | 10,299 | $59.0K | 0.00% | +10,299 | New |
| Jane Street Group, LLC | 12,961 | $74.3K | 0.00% | +12,961 | New |
| Mirador Capital Partners LP | 13,807 | $79.1K | 0.01% | −454−3.2% | Reduced |
| Atom Investors LP | 14,276 | $81.8K | 0.01% | +14,276 | New |
| Royal Bank of Canada | 22,652 | $130.0K | 0.00% | −250−1.1% | Reduced |
| GHP Investment Advisors, Inc. | 26,171 | $150.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 28,549 | $163.6K | 0.00% | +3,099+12.2% | Added |
| Susquehanna International Group, LLP | 30,735 | $176.1K | 0.00% | +30,735 | New |
| Prelude Capital Management, LLC | 35,770 | $205.0K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 43,026 | $246.5K | 0.00% | +43,026 | New |
| State Street Corp | 48,100 | $275.6K | 0.00% | +5,100+11.9% | Added |
| Newbridge Financial Services Group, Inc. | 70,000 | $401.1K | 0.10% | +70,000 | New |
| BlackRock, Inc. | 76,193 | $436.6K | 0.00% | +10,367+15.7% | Added |
| Geode Capital Management, LLC | 150,576 | $863.1K | 0.00% | +8,267+5.8% | Added |
| CM Management, LLC | 160,000 | $916.8K | 0.82% | +15,941+11.1% | Added |
| Vanguard Group Inc | 840,471 | $4.82M | 0.00% | −4,953−0.6% | Reduced |
| AIGH Capital Management LLC | 1,201,152 | $6.88M | 2.59% | +551,725+85.0% | Added |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 1,646,440 | $9.43M | 0.49% | +372,414+29.2% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,200−100.0% | Sold out |